Frederik Jensen-Hvid

Palle Juul Jensens Boulevard 99
Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Peroral endoscopic myotomy: a Danish single center 10-year follow-up study.

Peroral endoscopic myotomy: a Danish single center 10-year follow-up study.

Journal: Surgical endoscopy

Published: March 13, 2025

Long-term efficacy and quality of life after antireflux surgery.

Long-term efficacy and quality of life after antireflux surgery.

Journal: Surgical endoscopy

Published: September 25, 2024

Short communication: first case of bacteraemia caused by Dielma fastidiosa in a patient hospitalized with diverticulitis.

Short communication: first case of bacteraemia caused by Dielma fastidiosa in a patient hospitalized with diverticulitis.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: October 11, 2023

Should aspirin and PPIs be recommended for patients with Barrett's oesophagus?

Should aspirin and PPIs be recommended for patients with Barrett's oesophagus?

Journal: Lancet (London, England)

Published: July 02, 2018

Barrett's oesophagus: size does matter.

Barrett's oesophagus: size does matter.

Journal: Gut

Published: July 07, 2015

Benign and precursor lesions in the esophagus.

Benign and precursor lesions in the esophagus.

Journal: Annals of the New York Academy of Sciences

Published: October 01, 2014

Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.

Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 01, 2014

Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.

Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: June 02, 2014

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.

Journal: Clinical epidemiology

Published: December 19, 2013

Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.

Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.

Journal: Alimentary pharmacology & therapeutics

Published: June 03, 2013

Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain.

Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain.

Journal: Scandinavian journal of gastroenterology

Published: January 17, 2013

Incidence of adenocarcinoma among patients with Barrett's esophagus.

Incidence of adenocarcinoma among patients with Barrett's esophagus.

Journal: The New England journal of medicine

Published: October 15, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026